Victory Capital Management
RSLS

Victory Capital Management’s ReShape Lifesciences Inc. Common Stock RSLS Stock Holding History

Victory Capital Management’s Portfolio RSLS Stock Details RSLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-61
Closed – – 3754
2020
Q1 		$0 Buy
+61
New – ﹤0.01% 3834

Victory Capital Management's RSLS Position: Q2 2020 in Review

Victory Capital Management sold out of ReShape Lifesciences Inc. Common Stock (RSLS) in Q2 2020, closing a stake of 61 shares.

Victory Capital Management first reported a position in RSLS in Q1 2020 and held it in 1 quarter. The position peaked at $0 in Q1 2020. 0 funds tracked by Wall St. Rank hold RSLS as of Q2 2020.

  • Victory Capital Management reported no remaining ReShape Lifesciences Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 61 ReShape Lifesciences Inc. Common Stock shares in Q2 2020.
  • Victory Capital Management first reported a position in ReShape Lifesciences Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • Victory Capital Management's ReShape Lifesciences Inc. Common Stock position peaked at $0 in Q1 2020.
  • 0 funds tracked by Wall St. Rank held ReShape Lifesciences Inc. Common Stock as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.